The "team" you think you're a part of is as actually just the C-Suite. They have their own agenda, which is to maximize profits for shareholders. They are huge shareholders too I remind you. You are not part of the team. You are the equipment the team uses. Seriously, when was the last good deal where pharma C Suite declined so they could instead take care of their their reps? Thats right. Never. You are new to this industry.
Pipeline Question- Upcoming Interview
- Thread starter anonymous
- Start date
-
- Tags
- None
The "team" you think you're a part of is as actually just the C-Suite. They have their own agenda, which is to maximize profits for shareholders. They are huge shareholders too I remind you. You are not part of the team. You are the equipment the team uses. Seriously, when was the last good deal where pharma C Suite declined so they could instead take care of their their reps? Thats right. Never. You are new to this industry.
Pfizer bought Warner Lambert for $90B for only one reason, Lipitor. That was the first $10B a year drug for worldwide sales. Lovaza with its limited indication reached $1B a year sales. Vascepa with TG, CV and DM treatment and preventive indications will be huge! Just huge!
Vascepa's expected sales are $1.1 to $1.5 Bln by the year 2027 - 2028 with Teva expected to launch it's generic version by Q3 of the year 2029. No way, this drug hits $10 Bln/yr. I do this for a living, while you're hypothesizing based on a whim.
- Woody Nov 15, 2019 at 07:54: PM
Warner-Lambert which worked for Parke-Davis also had "Neurontin" a big seller and "Lyrica" another great drug. They also Benadryl, Listerine, Lubiderm, Certs, and many great OTC products. Pfizer is a First Class Joke.
“I do this for a living.” Are you an Merger and Acquisition Analyst for Wall Street? Go frick yourself. You’re a rep. This drug has 10B potential per every reputable source out there buddy.
I'm not your buddy. Each time you type, you prove your stupidity. Show all of these "every reputable sources" that state Vascepa will be $10 Bln/yr. You expect a product that is projected to bring in revenue between $350 and $450 Mln, this year, to hit 10 Bln/year in peak sales. Stop. You do not know what you are talking about, yet you spout your idiotic drivel, as though it is gospel. You're overmatched. You do not have my credentials, and I am not going to waste my time trying to convince a liberal arts grad about how ridiculous and uninformed he/she sounds.
I used to work in corporate pharma, so I like to hear what the sales reps say. Amarin is doing some great things with Vascepa, much better than what GSK did with Lovaza, and the 1 yr stock price is projected to hit from $29 to $35. That is great growth. .
P.S. I responded to you because I work as an analyst, now. Go fuck yourself. Frick is not a word.
Hold my beer! I used to work in Corporate Pharma...Ok Boomer! Were you responsible for the shiny new glossy sales piece for reps? You don’t know jack shite and aren’t privy to any high level discussions. $29-$35 in 1 year huh...? This lets me know I’m wasting my time.
Okay boomer to a 35 year old? Clown. This is an adult conversation. Come back when your retorts are not rife with stupidity. Most of you, pharma reps, are a joke. Stick to being an Uber Eats delivery driver, in a tie. University of Phoenix educated loser.
I have more news for you:
Call VAG or meet on political board for man on man anal
2986B
93063
818-361-5021
Off Paredo
Two stupids. Do you still see 10B in sales? Two ,fucking, idiots together!
I think Cafe Pharma is primarily made up of post by short interest betting the stock will go down. They have to create panic here to try to promote a sales force in crisis.
Agreed. I take Upper Management at their word when they say they have our best interest in mind. There is nothing to worry about as that’s just noise which never comes true.
Short it yes ! Then watch it crumble like this morning's shit